Celltrion Inc. announced on December 15 that the US Food and Drug Administration (US FDA) had approved Herzuma, a biosimilar to Roche Holding AG’s blockbuster breast cancer treatment, Herceptin (proper name: trastuzumab), on the 14th.Herceptin is the world’s most successful antibody drug that genera